false--12-31Q320172017-10-010000078003Large Accelerated FilerPFEP24MP10YP3Y3800000000.025P3YP18M4800000000P5Y62000000P9YP9YP10YP36M1480700000015906000000P12Y60900000059000000017200000000033000000940000000.0020.0420.010.002500000127000000790000009400000042250000003072000000870000001700000000 0000078003 2017-01-01 2017-10-01 0000078003 2017-11-06 0000078003 2017-07-03 2017-10-01 0000078003 2016-01-01 2016-10-02 0000078003 2016-07-04 2016-10-02 0000078003 pfe:LaboratorioTeutoBrasileroMember 2017-06-30 0000078003 2016-12-31 0000078003 2017-10-01 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-02-03 0000078003 2015-12-31 0000078003 2016-10-02 0000078003 pfe:AnacorMember 2016-06-24 0000078003 pfe:AccountingStandardsUpdate201609StatutoryTaxWithholdingComponentMember 2016-01-01 2016-10-02 0000078003 pfe:MedivationMember 2016-09-28 0000078003 pfe:AnacorMember 2016-06-24 2016-06-24 0000078003 pfe:BambooTherapeuticsMember 2016-08-01 2016-08-01 0000078003 pfe:MedivationMember 2017-07-03 2017-10-01 0000078003 pfe:BambooTherapeuticsMember 2016-08-01 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-01-05 0000078003 pfe:AstraZenecaMember 2017-04-03 2017-07-02 0000078003 pfe:MedivationMember 2016-09-28 2016-09-28 0000078003 pfe:AstraZenecaMember 2016-12-22 2016-12-22 0000078003 pfe:AstraZenecaMember 2016-12-22 0000078003 pfe:LaboratorioTeutoBrasileroMember pfe:LaboratorioTeutoBrasileroMember 2017-06-30 0000078003 pfe:MerckKGaAMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:CollaborativeArrangementMember 2017-01-01 2017-10-01 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2016-10-06 0000078003 pfe:MedivationMember us-gaap:DevelopedTechnologyRightsMember 2016-09-28 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember pfe:LaboratorioTeutoBrasileroMember 2016-01-01 2016-10-02 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-01-01 2017-10-01 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-02-03 2017-02-03 0000078003 pfe:MerckKGaAMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:CollaborativeArrangementMember 2017-01-01 2017-04-02 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-10-01 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-07-03 2017-10-01 0000078003 pfe:BambooTherapeuticsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 pfe:MedivationMember 2016-09-29 2017-10-01 0000078003 pfe:LaboratorioTeutoBrasileroMember 2017-01-01 2017-10-01 0000078003 pfe:BambooTherapeuticsMember us-gaap:InProcessResearchAndDevelopmentMember 2016-08-01 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-03 2017-02-03 0000078003 pfe:AstraZenecaMember us-gaap:InProcessResearchAndDevelopmentMember 2016-12-22 0000078003 pfe:AstraZenecaMember us-gaap:DevelopedTechnologyRightsMember 2016-12-22 0000078003 pfe:HisunPfizerPharmaceuticalsCoLtdMember 2017-10-01 0000078003 pfe:AstraZenecaMember us-gaap:ScenarioForecastMember 2018-01-01 2018-04-01 0000078003 pfe:HisunPfizerPharmaceuticalsCoLtdMember 2016-10-02 0000078003 pfe:AstraZenecaMember us-gaap:MinimumMember 2016-12-22 2016-12-22 0000078003 pfe:BambooTherapeuticsMember 2016-01-01 2016-04-03 0000078003 pfe:HisunPfizerPharmaceuticalsCoLtdMember 2016-01-01 2016-10-02 0000078003 pfe:MedivationMember us-gaap:InProcessResearchAndDevelopmentMember 2016-09-28 0000078003 pfe:AstraZenecaMember us-gaap:MaximumMember 2016-12-22 2016-12-22 0000078003 pfe:MedivationMember 2016-12-31 0000078003 pfe:AnacorMember us-gaap:InProcessResearchAndDevelopmentMember 2016-06-24 0000078003 pfe:MedivationMember 2017-01-01 2017-10-01 0000078003 pfe:MedivationMember us-gaap:DevelopedTechnologyRightsMember 2016-09-28 2016-09-28 0000078003 us-gaap:EmployeeSeveranceMember 2017-01-01 2017-10-01 0000078003 pfe:AssetImpairmentsMember 2017-01-01 2017-10-01 0000078003 us-gaap:OtherRestructuringMember 2017-01-01 2017-10-01 0000078003 us-gaap:EmployeeSeveranceMember 2017-10-01 0000078003 us-gaap:OtherRestructuringMember 2017-10-01 0000078003 us-gaap:EmployeeSeveranceMember 2016-12-31 0000078003 us-gaap:OtherRestructuringMember 2016-12-31 0000078003 pfe:AssetImpairmentsMember 2016-12-31 0000078003 pfe:AssetImpairmentsMember 2017-10-01 0000078003 pfe:ManufacturingPlantNetworkOptimizationMember pfe:EnterprisewideCostReductionProductivityPlanMember 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:ManufacturingOperationsMember 2016-01-01 2016-10-02 0000078003 pfe:EnterprisewideCostReductionProductivityPlanMember 2017-01-01 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 us-gaap:CorporateNonSegmentMember 2016-07-04 2016-10-02 0000078003 us-gaap:OperatingSegmentsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 us-gaap:OtherCurrentLiabilitiesMember 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:WorldwideResearchandDevelopmentandGlobalProductDevelopmentMember 2016-01-01 2016-10-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:ManufacturingOperationsMember 2017-01-01 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:WorldwideResearchandDevelopmentandGlobalProductDevelopmentMember 2017-01-01 2017-10-01 0000078003 us-gaap:CorporateNonSegmentMember 2017-07-03 2017-10-01 0000078003 us-gaap:CorporateNonSegmentMember 2017-01-01 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:CentralizationofCorporateandPlatformFunctionsMember pfe:EnterprisewideCostReductionProductivityPlanMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:HospiraMember pfe:BusinessIntegrationCostsMember 2017-01-01 2017-10-01 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember 2016-12-31 0000078003 us-gaap:OperatingSegmentsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EnterprisewideCostReductionProductivityPlanMember 2017-10-01 0000078003 us-gaap:OtherCurrentLiabilitiesMember 2016-12-31 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:WorldwideResearchandDevelopmentandGlobalProductDevelopmentMember 2016-07-04 2016-10-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:WorldwideResearchandDevelopmentandGlobalProductDevelopmentMember 2017-07-03 2017-10-01 0000078003 pfe:BusinessIntegrationCostsMember 2017-01-01 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 us-gaap:CorporateNonSegmentMember 2016-01-01 2016-10-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:ManufacturingOperationsMember 2016-07-04 2016-10-02 0000078003 us-gaap:OperatingSegmentsMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:ManufacturingOperationsMember 2017-07-03 2017-10-01 0000078003 pfe:HospiraMember us-gaap:ScenarioForecastMember 2015-09-03 2018-09-03 0000078003 pfe:HospiraMember pfe:ReturnofAcquiredRightsMember 2015-01-01 2015-12-31 0000078003 pfe:HospiraMember country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 us-gaap:CostOfSalesMember 2017-07-03 2017-10-01 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-10-01 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-01 2016-10-02 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-10-01 0000078003 us-gaap:CostOfSalesMember 2017-01-01 2017-10-01 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-07-04 2016-10-02 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-03 2017-10-01 0000078003 pfe:OtherIncomeExpenseMember 2016-01-01 2016-10-02 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2017-07-03 2017-10-01 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2016-07-04 2016-10-02 0000078003 us-gaap:CostOfSalesMember 2016-07-04 2016-10-02 0000078003 us-gaap:CostOfSalesMember 2016-01-01 2016-10-02 0000078003 pfe:OtherIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 pfe:OtherIncomeExpenseMember 2017-01-01 2017-10-01 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-10-02 0000078003 pfe:OtherIncomeExpenseMember 2017-07-03 2017-10-01 0000078003 pfe:HospiraMember 2015-09-03 2015-09-03 0000078003 us-gaap:DevelopedTechnologyRightsMember 2017-01-01 2017-10-01 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:DevelopedTechnologyRightsMember 2017-10-01 0000078003 us-gaap:FairValueInputsLevel3Member us-gaap:DevelopedTechnologyRightsMember 2017-10-01 0000078003 us-gaap:FairValueInputsLevel1Member us-gaap:DevelopedTechnologyRightsMember 2017-10-01 0000078003 us-gaap:DevelopedTechnologyRightsMember 2017-10-01 0000078003 pfe:LaboratorioTeutoBrasileroMember 2016-10-02 0000078003 pfe:KingMember pfe:OtherInProcessResearchandDevelopmentMember 2016-07-04 2016-10-02 0000078003 pfe:HospiraMember us-gaap:OperatingSegmentsMember us-gaap:DevelopedTechnologyRightsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember pfe:ViivHealthcareLimitedMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnoPharmaMember us-gaap:InProcessResearchAndDevelopmentMember 2016-01-01 2016-10-02 0000078003 us-gaap:InProcessResearchAndDevelopmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnoPharmaMember us-gaap:InProcessResearchAndDevelopmentMember 2016-07-04 2016-10-02 0000078003 us-gaap:PendingLitigationMember pfe:PatentMatterMember 2017-07-03 2017-10-01 0000078003 us-gaap:DistributionRightsMember 2017-01-01 2017-10-01 0000078003 pfe:XtandiMember 2017-07-03 2017-10-01 0000078003 pfe:LaboratorioTeutoBrasileroMember 2016-01-01 2016-10-02 0000078003 us-gaap:DevelopedTechnologyRightsMember 2016-01-01 2016-10-02 0000078003 pfe:HospiraMember pfe:OtherInProcessResearchandDevelopmentMember 2016-01-01 2016-10-02 0000078003 pfe:XtandiMember 2017-01-01 2017-10-01 0000078003 pfe:KingMember pfe:OtherInProcessResearchandDevelopmentMember 2016-01-01 2016-10-02 0000078003 pfe:EnbrelMember us-gaap:CollaborativeArrangementCopromotionMember 2017-07-03 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember pfe:ViivHealthcareLimitedMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 us-gaap:DistributionRightsMember 2017-07-03 2017-10-01 0000078003 us-gaap:PendingLitigationMember pfe:CelebrexandBextraMember 2016-01-01 2016-10-02 0000078003 us-gaap:PendingLitigationMember pfe:CelebrexMember 2017-07-03 2017-10-01 0000078003 pfe:EnbrelMember us-gaap:CollaborativeArrangementCopromotionMember 2017-01-01 2017-10-01 0000078003 pfe:OtherInProcessResearchandDevelopmentMember 2016-01-01 2016-10-02 0000078003 us-gaap:DistributionRightsMember 2016-01-01 2016-10-02 0000078003 us-gaap:PendingLitigationMember pfe:CelebrexMember 2017-01-01 2017-10-01 0000078003 us-gaap:PendingLitigationMember pfe:PatentMatterMember 2017-01-01 2017-10-01 0000078003 pfe:HospiraMember us-gaap:OperatingSegmentsMember us-gaap:DevelopedTechnologyRightsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-01-01 2017-10-01 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2016-12-31 0000078003 us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0000078003 us-gaap:AccumulatedTranslationAdjustmentMember 2017-10-01 0000078003 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-10-01 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-10-01 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-10-01 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2016-12-31 0000078003 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-12-31 0000078003 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-12-31 0000078003 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-10-01 0000078003 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-01 2017-10-01 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2017-10-01 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2017-10-01 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2017-01-01 2017-10-01 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2017-01-01 2017-10-01 0000078003 us-gaap:CorporateDebtSecuritiesMember 2017-10-01 0000078003 us-gaap:USGovernmentDebtSecuritiesMember 2017-10-01 0000078003 pfe:WesternEuropeanandOtherGovernmentDebtMember 2017-10-01 0000078003 pfe:WesternEuropeanAsianandOtherGovernmentDebtMember 2017-10-01 0000078003 pfe:TimeDepositsCorporateDebtAndOtherMember 2017-10-01 0000078003 pfe:SupranationalDebtMember 2017-10-01 0000078003 us-gaap:GovernmentNationalMortgageAssociationCertificatesAndObligationsGNMAMember 2017-10-01 0000078003 pfe:WesternEuropeanScandinaviaAndOtherGovernmentAgencyDebtMember 2017-10-01 0000078003 us-gaap:AssetBackedSecuritiesMember 2017-10-01 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-10-01 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-10-01 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-10-01 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2017-07-03 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-07-03 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:OtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-07-03 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-07-03 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-07-03 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-02 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-07-03 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-07-03 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 pfe:OtherDerivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-07-04 2016-10-02 0000078003 us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-10-01 0000078003 us-gaap:OtherComprehensiveIncomeMember 2017-07-03 2017-10-01 0000078003 us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-10-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-07-03 2017-10-01 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2017-10-01 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:DevelopedTechnologyRightsMember pfe:BesponsaMember country:US 2017-10-01 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember 2016-12-31 0000078003 us-gaap:CashAndCashEquivalentsMember 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2017-10-01 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember 2017-10-01 0000078003 us-gaap:UnsecuredDebtMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2016-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:DevelopedTechnologyRightsMember pfe:BesponsaMember us-gaap:EuropeanUnionMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember 2016-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2017-10-01 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2017-10-01 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2016-12-31 0000078003 us-gaap:FairValueMeasurementsRecurringMember 2017-10-01 0000078003 us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember 2016-12-31 0000078003 us-gaap:SeniorNotesMember 2017-04-02 0000078003 us-gaap:DevelopedTechnologyRightsMember pfe:BesponsaMember country:US 2017-10-01 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember pfe:ForeignCurrencyLongTermDebtMember 2017-10-01 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember 2017-10-01 0000078003 us-gaap:DevelopedTechnologyRightsMember pfe:BesponsaMember us-gaap:EuropeanUnionMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember 2016-12-31 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-12-31 0000078003 us-gaap:CommercialPaperMember 2016-12-31 0000078003 pfe:EuroLongtermDebtMember us-gaap:SeniorNotesMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DevelopedTechnologyRightsMember pfe:BesponsaMember country:US 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2016-12-31 0000078003 us-gaap:ForeignExchangeForwardMember 2017-10-01 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2017-10-01 0000078003 us-gaap:SeniorNotesMember us-gaap:MaximumMember pfe:GermanGovernmentBondRateMember 2017-01-01 2017-10-01 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember 2016-12-31 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DevelopedTechnologyRightsMember pfe:BesponsaMember us-gaap:EuropeanUnionMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember 2017-10-01 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2016-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember 2016-12-31 0000078003 us-gaap:TechnologySectorMember 2017-01-01 2017-10-01 0000078003 us-gaap:CommercialPaperMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2016-12-31 0000078003 us-gaap:InterestRateContractMember 2017-10-01 0000078003 pfe:BesponsaMember country:US 2017-08-31 0000078003 pfe:BesponsaMember us-gaap:EuropeanUnionMember 2017-06-30 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2016-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember 2016-12-31 0000078003 us-gaap:ShortTermDebtMember 2017-10-01 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2017-10-01 0000078003 us-gaap:DebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-12-31 0000078003 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:LongTermDebtMember 2016-12-31 0000078003 us-gaap:ShortTermDebtMember 2016-12-31 0000078003 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2017-10-01 0000078003 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-10-01 0000078003 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2017-10-01 0000078003 us-gaap:LongTermDebtMember 2017-10-01 0000078003 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember 2017-10-01 0000078003 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2017-10-01 0000078003 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:DebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2017-10-01 0000078003 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 pfe:SeniorUnsecuredEuroDebtZeroPercentDue2020Member us-gaap:SeniorNotesMember 2017-10-01 0000078003 pfe:SeniorUnsecuredEuroDebtOnePointZeroPercentDue2027Member us-gaap:SeniorNotesMember 2017-10-01 0000078003 pfe:SeniorUnsecuredDebtFourPointTwoPercentDue2047Member us-gaap:SeniorNotesMember 2017-10-01 0000078003 pfe:SeniorUnsecuredEuroDebtThreemonthEURIBORPlus0.20FloatingRateNotesMember us-gaap:SeniorNotesMember 2017-10-01 0000078003 us-gaap:SeniorNotesMember 2017-10-01 0000078003 pfe:SeniorUnsecuredEuroDebtPointTwofivePercentDue2022Member us-gaap:SeniorNotesMember 2017-10-01 0000078003 pfe:LongtermInvestmentsMember 2017-10-01 0000078003 us-gaap:OtherNoncurrentAssetsMember 2017-10-01 0000078003 us-gaap:OtherCurrentAssetsMember 2016-12-31 0000078003 us-gaap:ShortTermInvestmentsMember 2017-10-01 0000078003 us-gaap:LongTermDebtMember 2016-12-31 0000078003 pfe:LongtermInvestmentsMember 2016-12-31 0000078003 pfe:ShortTermDebtAndCurrentPortionofLongTermDebtMember 2017-10-01 0000078003 us-gaap:ShortTermInvestmentsMember 2016-12-31 0000078003 pfe:ShortTermDebtAndCurrentPortionofLongTermDebtMember 2016-12-31 0000078003 us-gaap:LongTermDebtMember 2017-10-01 0000078003 us-gaap:CashAndCashEquivalentsMember 2016-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember 2016-12-31 0000078003 us-gaap:OtherCurrentAssetsMember 2017-10-01 0000078003 pfe:BesponsaMember us-gaap:EuropeanUnionMember 2017-06-01 2017-06-30 0000078003 pfe:BesponsaMember country:US 2017-08-01 2017-08-31 0000078003 pfe:SeniorUnsecuredEuroDebtThreemonthEURIBORPlus0.20FloatingRateNotesMember us-gaap:SeniorNotesMember pfe:EURIBORMember 2017-01-01 2017-10-01 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2017-07-03 2017-10-01 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2016-07-04 2016-10-02 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2017-01-01 2017-10-01 0000078003 us-gaap:DevelopedTechnologyRightsMember pfe:BesponsaMember 2017-10-01 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2016-01-01 2016-10-02 0000078003 us-gaap:InProcessResearchAndDevelopmentMember pfe:EucrisaMember 2017-10-01 0000078003 us-gaap:DevelopedTechnologyRightsMember 2016-12-31 0000078003 us-gaap:TradeNamesMember 2016-12-31 0000078003 pfe:LicensingAgreementsAndOtherMember 2016-12-31 0000078003 us-gaap:InProcessResearchAndDevelopmentMember 2016-12-31 0000078003 us-gaap:InProcessResearchAndDevelopmentMember 2017-10-01 0000078003 us-gaap:TradeNamesMember 2017-10-01 0000078003 us-gaap:TradeNamesMember 2016-12-31 0000078003 pfe:LicensingAgreementsAndOtherMember 2017-10-01 0000078003 us-gaap:TradeNamesMember 2017-10-01 0000078003 pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthSegmentMember 2017-10-01 0000078003 pfe:InnovativeHealthSegmentMember 2016-12-31 0000078003 pfe:EssentialHealthSegmentMember 2016-12-31 0000078003 pfe:InnovativeHealthSegmentMember 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember us-gaap:InProcessResearchAndDevelopmentMember pfe:EssentialHealthSegmentMember 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember us-gaap:DevelopedTechnologyRightsMember pfe:EssentialHealthSegmentMember 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:DevelopedTechnologyRightsMember pfe:PfizersWorldwideResearchandDevelopmentMember 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:TradeNamesMember pfe:PfizersWorldwideResearchandDevelopmentMember 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember us-gaap:DevelopedTechnologyRightsMember pfe:InnovativeHealthSegmentMember 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:EssentialHealthSegmentMember 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:InnovativeHealthSegmentMember 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:InnovativeHealthSegmentMember 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:EssentialHealthSegmentMember 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember us-gaap:InProcessResearchAndDevelopmentMember pfe:InnovativeHealthSegmentMember 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:TradeNamesMember pfe:PfizersWorldwideResearchandDevelopmentMember 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:InProcessResearchAndDevelopmentMember pfe:PfizersWorldwideResearchandDevelopmentMember 2017-10-01 0000078003 us-gaap:DevelopedTechnologyRightsMember pfe:EucrisaMember 2017-10-01 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2016-07-04 2016-10-02 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-01-01 2016-10-02 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-01-01 2016-10-02 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-07-04 2016-10-02 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-07-04 2016-10-02 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-10-01 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2017-07-03 2017-10-01 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-07-03 2017-10-01 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-01-01 2017-10-01 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-07-04 2016-10-02 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-01-01 2016-10-02 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-07-03 2017-10-01 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-07-03 2017-10-01 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2017-01-01 2017-10-01 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-10-01 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2016-01-01 2016-10-02 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-10-01 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-10-01 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-10-01 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2017-10-01 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-01-31 0000078003 pfe:HospiraMember country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-04-01 2017-04-30 0000078003 us-gaap:StockOptionMember 2016-07-04 2016-10-02 0000078003 us-gaap:StockOptionMember 2017-07-03 2017-10-01 0000078003 us-gaap:StockOptionMember 2017-01-01 2017-10-01 0000078003 us-gaap:StockOptionMember 2016-01-01 2016-10-02 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusZydusMember us-gaap:PendingLitigationMember pfe:XeljanzMember 2017-03-01 2017-03-31 0000078003 pfe:ViolationofAntitrustLawsMember pfe:PhenytoinSodiumCapsulesMember 2016-12-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusPrinstonandBreckenridgeMember us-gaap:PendingLitigationMember pfe:XeljanzMember 2017-03-01 2017-03-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMicroLabsMember us-gaap:PendingLitigationMember pfe:XeljanzMember 2017-02-01 2017-02-28 0000078003 pfe:PatentInfringementMember pfe:PfizerandBMSVersusSeveralGenericManufacturersMember us-gaap:PendingLitigationMember pfe:EliquisMember 2017-02-01 2017-04-30 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-02-02 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-10-01 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:JudicialRulingMember pfe:ToviazMember 2017-01-01 2017-01-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:JudicialRulingMember pfe:ToviazMember 2017-07-01 2017-07-31 0000078003 pfe:StateofIllinoisVersusPfizerMember us-gaap:PendingLitigationMember pfe:AverageWholesalePriceMember 2017-10-01 0000078003 pfe:JanssenandNewYorkUniversityVersusHospiraCelltrionHealthcareandCelltrionInc.Member us-gaap:PendingLitigationMember pfe:InflectraMember 2015-03-01 2015-03-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazMember 2015-01-01 2015-01-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusSeveralGenericManufacturersMember us-gaap:SettledLitigationMember pfe:ToviazMember 2015-06-01 2015-07-31 0000078003 pfe:HospiraVersusParMember us-gaap:PendingLitigationMember pfe:PrecedexPremixMember 2016-08-01 2016-08-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusBreckenridgeMember us-gaap:PendingLitigationMember pfe:XeljanzMember us-gaap:SubsequentEventMember 2017-10-02 2017-10-31 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-02-06 2017-02-06 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-02-06 2017-05-19 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-02-02 2017-02-02 0000078003 pfe:RegentsVersusMedivationMember us-gaap:SettledLitigationMember pfe:XtandiMember 2017-04-01 2017-04-30 0000078003 pfe:JanssenandNewYorkUniversityVersusHospiraCelltrionHealthcareandCelltrionInc.Member us-gaap:SettledLitigationMember pfe:InflectraMember 2015-03-01 2015-03-31 0000078003 pfe:PatentInfringementMember pfe:WyethVersusSunMember us-gaap:PendingLitigationMember pfe:BosulifMember 2017-09-01 2017-09-30 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazMember 2016-07-01 2016-07-31 0000078003 pfe:HospiraVersusAmnealPharmaceuticalsLLCMember us-gaap:PendingLitigationMember pfe:PrecedexPremixMember 2015-06-01 2015-06-30 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusSeveralGenericManufacturersMember us-gaap:PendingLitigationMember pfe:ToviazMember 2015-07-01 2015-07-31 0000078003 pfe:HospiraVersusFreseniusMember us-gaap:PendingLitigationMember pfe:PrecedexPremixMember 2015-12-01 2015-12-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:JudicialRulingMember pfe:ToviazMember 2017-02-01 2017-02-28 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazCompositionofmatterPatentsMember 2016-01-01 2016-01-31 0000078003 pfe:MylotargMember us-gaap:ProFormaMember 2017-10-01 0000078003 pfe:EnvironmentalRemediationLitigationMember 2013-03-01 2013-03-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazMember 2016-01-01 2016-01-31 0000078003 us-gaap:PendingLitigationMember pfe:CelebrexMember us-gaap:SubsequentEventMember 2017-10-02 2017-10-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazCompositionofmatterPatentsMember 2015-01-01 2015-01-31 0000078003 pfe:JanssenandNewYorkUniversityVersusHospiraCelltrionHealthcareandCelltrionInc.Member pfe:InflectraMember 2015-03-01 2015-03-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazMember 2013-06-01 2013-06-30 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:JudicialRulingMember pfe:ToviazMember 2017-08-01 2017-08-10 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-02-06 0000078003 pfe:PfizerVersusBMSE.R.SquibbSonsOnoPharmaceuticalandTasukuHonjoMember us-gaap:PendingLitigationMember pfe:PatentInfringementMember pfe:BavencioMember 2017-07-01 2017-07-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusSeveralGenericManufacturersMember us-gaap:PendingLitigationMember pfe:ToviazCompositionofmatterPatentsMember 2013-06-01 2013-06-30 0000078003 pfe:ClassActionVersusAmericanOpticalCorporationAndVariousOtherDefendantsMember us-gaap:PendingLitigationMember us-gaap:DamagesFromProductDefectsMember 2017-10-01 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-05-19 2017-05-19 0000078003 pfe:MylotargMember us-gaap:ProFormaMember 2017-01-01 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember 2016-07-04 2016-10-02 0000078003 currency:EUR pfe:DevelopedEuropeMember 2016-01-01 2016-10-02 0000078003 us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:HISMember 2016-07-04 2016-10-02 0000078003 currency:EUR pfe:DevelopedEuropeMember 2017-07-03 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember 2017-07-03 2017-10-01 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:HISMember 2017-07-03 2017-10-01 0000078003 us-gaap:CorporateNonSegmentMember us-gaap:ScenarioAdjustmentMember 2016-01-01 2016-10-02 0000078003 us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-10-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:HISMember 2016-01-01 2016-10-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:HISMember 2017-01-01 2017-10-01 0000078003 us-gaap:CorporateNonSegmentMember us-gaap:ScenarioAdjustmentMember 2016-07-04 2016-10-02 0000078003 currency:EUR pfe:DevelopedEuropeMember 2017-01-01 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember 2017-07-03 2017-10-01 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-10-02 0000078003 pfe:OtherUnallocatedMember us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-10-02 0000078003 pfe:OtherUnallocatedMember us-gaap:MaterialReconcilingItemsMember 2017-07-03 2017-10-01 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-10-01 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-10-02 0000078003 us-gaap:OperatingSegmentsMember 2017-01-01 2017-10-01 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-10-01 0000078003 us-gaap:OperatingSegmentsMember 2016-07-04 2016-10-02 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2017-07-03 2017-10-01 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2017-07-03 2017-10-01 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-10-02 0000078003 us-gaap:OperatingSegmentsMember 2016-01-01 2016-10-02 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2016-07-04 2016-10-02 0000078003 pfe:OtherUnallocatedMember us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-10-01 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-10-01 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2017-07-03 2017-10-01 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2016-07-04 2016-10-02 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2016-07-04 2016-10-02 0000078003 pfe:OtherUnallocatedMember us-gaap:MaterialReconcilingItemsMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:PremarinFamilyMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:InflectraRemsimaMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:AllOtherRareDiseaseProductsMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:AllianceBiopharmaceuticalsMember pfe:InnovativeHealthandEssentialHealthMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:CentreOneMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:BosulifMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ToviazMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ChantixChampixMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:XeljanzMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:SulperazonMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:VfendMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:CelebrexMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:PremarinFamilyMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthandEssentialHealthMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:AllOtherSterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthandEssentialHealthMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EnbrelMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:HospiraInfusionSystemsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:SomavertMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:TygacilMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:AllOtherPeriLOEProductsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:SulperazonMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:BeneFIXMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:CentreOneMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XtandiAllianceMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ViagraMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:FSMEIMMUNTicoVacMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:XeljanzMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EffexorMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:ConsumerHealthcareMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ChantixChampixMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:PrecedexMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:OtherOncologyProductsMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:LipitorMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:LipitorMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:OtherLegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EffexorMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:VfendMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:AllOtherSterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:PrevnarPrevenarFamilyMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:IbranceMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZoloftMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:OtherVaccinesProductsMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ViagraMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:HospiraInfusionSystemsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:OtherOncologyProductsMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:AllOtherInflammationandImmunologyProductsMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:PrecedexMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:TygacilMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:InflectraRemsimaMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EpiPenMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:PristiqMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZoloftMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:LyricaMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XanaxXanaxXRMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:PrecedexMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:PremarinFamilyMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XanaxXanaxXRMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:AllOtherSterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:BMP2Member pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:AllOtherInternalMedicineMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ViagraMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:InflectraRemsimaMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:FSMEIMMUNTicoVacMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:OtherOncologyProductsMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EpiPenMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:ViagraMember pfe:InnovativeHealthandEssentialHealthMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:BosulifMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EpiPenMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:AllOtherPeriLOEProductsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:FragminMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:EliquisMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:ConsumerHealthcareMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:CelebrexMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XtandiAllianceMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EucrisaMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:EliquisMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:XeljanzMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:LyricaMember pfe:InnovativeHealthandEssentialHealthMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EnbrelMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ToviazMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:LyricaMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ViagraMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:LipitorMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:AllOtherRareDiseaseProductsMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZithromaxZmaxMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:AllOtherInflammationandImmunologyProductsMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:AllOtherSterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ZyvoxMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:OtherLegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:OtherOncologyProductsMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:AllOtherBiosimilarsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XtandiAllianceMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:AllOtherRareDiseaseProductsMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:NorvascMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:BMP2Member pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:HospiraInfusionSystemsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ZyvoxMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:GenotropinMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:AllOtherPeriLOEProductsMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:OtherLegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:MedrolMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:BosulifMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InlytaMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:VfendMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ToviazMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:MedrolMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:NorvascMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:SutentMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:LyricaMember pfe:InnovativeHealthandEssentialHealthMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:IbranceMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:FragminMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:CentreOneMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:FSMEIMMUNTicoVacMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:NorvascMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:ReFactoAfXynthaMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:ViagraMember pfe:InnovativeHealthandEssentialHealthMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ViagraMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:BeneFIXMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EnbrelMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ZyvoxMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:ConsumerHealthcareMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:LyricaMember pfe:InnovativeHealthandEssentialHealthMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:AllOtherInternalMedicineMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ViagraMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:AllianceBiopharmaceuticalsMember pfe:InnovativeHealthandEssentialHealthMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:PristiqMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:GenotropinMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EucrisaMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:SutentMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XanaxXanaxXRMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:LyricaMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:AllOtherPeriLOEProductsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:PrecedexMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthandEssentialHealthMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:LyricaMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ToviazMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:OtherVaccinesProductsMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:RevatioMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:GenotropinMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XalkoriMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XalatanXalacomMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZoloftMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:AllOtherBiosimilarsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EpiPenMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:FragminMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:RelpaxMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:AllOtherInflammationandImmunologyProductsMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:EliquisMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:VfendMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:RelpaxMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:ReFactoAfXynthaMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:ReFactoAfXynthaMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XtandiAllianceMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:SutentMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:RevatioMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:SutentMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:AllOtherInflammationandImmunologyProductsMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EucrisaMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XalkoriMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:PremarinFamilyMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EnbrelMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:AllianceBiopharmaceuticalsMember pfe:InnovativeHealthandEssentialHealthMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:OtherVaccinesProductsMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:FragminMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:HospiraInfusionSystemsMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZithromaxZmaxMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:AllOtherBiosimilarsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:XeljanzMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:BeneFIXMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:LyricaMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ChantixChampixMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:RelpaxMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:AllOtherBiosimilarsMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:BosulifMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:OtherVaccinesProductsMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:PrevnarPrevenarFamilyMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:SomavertMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:LyricaMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthandEssentialHealthMember 2016-01-01 2016-10-02 0000078003 pfe:AllianceBiopharmaceuticalsMember pfe:InnovativeHealthandEssentialHealthMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZithromaxZmaxMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:IbranceMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XalatanXalacomMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:SulperazonMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZoloftMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:IbranceMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:AllOtherInternalMedicineMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EffexorMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XalkoriMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:RevatioMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:MedrolMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:SomavertMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:CelebrexMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ViagraMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InlytaMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:MedrolMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:GenotropinMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InlytaMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:AllOtherInternalMedicineMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XalatanXalacomMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InlytaMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:BMP2Member pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:PristiqMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:InflectraRemsimaMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:ViagraMember pfe:InnovativeHealthandEssentialHealthMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:CelebrexMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:PrevnarPrevenarFamilyMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ZyvoxMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EucrisaMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:NorvascMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XalkoriMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:SulperazonMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:FSMEIMMUNTicoVacMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:ConsumerHealthcareMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:SomavertMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:BMP2Member pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:AllOtherRareDiseaseProductsMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:PrevnarPrevenarFamilyMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ViagraMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:PristiqMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:RelpaxMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:RevatioMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:TygacilMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:LyricaMember pfe:InnovativeHealthandEssentialHealthMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:LyricaMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:EliquisMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:CentreOneMember pfe:EssentialHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ChantixChampixMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:OtherLegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XanaxXanaxXRMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:ViagraMember pfe:InnovativeHealthandEssentialHealthMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XalatanXalacomMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:BeneFIXMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZithromaxZmaxMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:InnovativeHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:ReFactoAfXynthaMember pfe:InnovativeHealthSegmentMember 2017-07-03 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:LyricaMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-10-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:TygacilMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:LipitorMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-10-01 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EffexorMember pfe:EssentialHealthSegmentMember 2016-07-04 2016-10-02 0000078003 pfe:DevelopedEuropeMember 2017-01-01 2017-10-01 0000078003 pfe:EmergingMarketsMember 2017-01-01 2017-10-01 0000078003 pfe:DevelopedEuropeMember 2017-07-03 2017-10-01 0000078003 country:US 2017-07-03 2017-10-01 0000078003 country:US 2017-01-01 2017-10-01 0000078003 pfe:EmergingMarketsMember 2017-07-03 2017-10-01 0000078003 country:US 2016-07-04 2016-10-02 0000078003 pfe:DevelopedRestOfWorldMember 2016-01-01 2016-10-02 0000078003 pfe:DevelopedRestOfWorldMember 2017-07-03 2017-10-01 0000078003 pfe:DevelopedEuropeMember 2016-01-01 2016-10-02 0000078003 pfe:DevelopedRestOfWorldMember 2017-01-01 2017-10-01 0000078003 pfe:DevelopedEuropeMember 2016-07-04 2016-10-02 0000078003 pfe:EmergingMarketsMember 2016-07-04 2016-10-02 0000078003 pfe:EmergingMarketsMember 2016-01-01 2016-10-02 0000078003 pfe:DevelopedRestOfWorldMember 2016-07-04 2016-10-02 0000078003 country:US 2016-01-01 2016-10-02 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:ScenarioAdjustmentMember pfe:PfizersWorldwideResearchandDevelopmentandPfizersGlobalProductDevelopmentMember 2016-07-04 2016-10-02 0000078003 currency:EUR pfe:DevelopedEuropeMember 2016-07-04 2016-10-02 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:ScenarioAdjustmentMember pfe:PfizersWorldwideResearchandDevelopmentandPfizersGlobalProductDevelopmentMember 2016-01-01 2016-10-02 xbrli:shares pfe:Operating_Segment xbrli:pure iso4217:USD iso4217:USD xbrli:shares iso4217:GBP pfe:Claim pfe:lagoon pfe:Patents pfe:Defendant iso4217:EUR